Background This review's goals were to investigate apremilast's efficacy versus placebo in
palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP), and apremilast's efficacy …

Background The comparative efficacy of biologics and small-molecule inhibitors in treating
palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP) remains uncertain …

Background Psoriasis, a chronic inflammatory disease affecting the skin, joints, and nails (2-
3% worldwide), significantly affects quality of life. Genetic and environmental factors also …

Introduction. Despite the availability of effective biologic therapies for psoriasis, there is no
gold‐standard treatment for nonpustular palmoplantar psoriasis (ppPsO). Methods. G …

Background: Psoriasis is an inflammatory systemic disease with a chronic relapsing course.
Methotrexate, a dihydrofolate reductase inhibitor, and Apremilast, an oral …

Palmoplantar psoriasis is a type of psoriasis which predominantly involves palms and soles.
Current therapeutic effects are limited with potentially significant adverse effects. 1 We read …

Background Psoriasis, a chronic inflammatory disease affecting the skin, joints, and nails (2-
3% worldwide), significantly affects quality of life. Genetic and environmental factors also …

Background Psoriasis, a chronic inflammatory disease affecting the skin, joints, and nails (2-
3% worldwide), significantly affects quality of life. Genetic and environmental factors also …

Aim: To assess the effectiveness of Methotrexate v/s Dapsone/ASST in treating Chronic
Urticaria. Materials and methods: A prospective comparison research was conducted on 200 …

Background: Psoriasis is a chronic inflammatory systemic condition depicting a high relapse
rate. The mainstream drugs for treating psoriasis in current times are phosphodiesterase …